Thermo Fisher Scientific | الأصول



Assets تغيير تاريخ
Abbott USD 81.45B 34M 2025-03
Agilent USD 11.91B 68M 2025-01
Becton, Dickinson and Co. USD 54.67B 2.62B 2024-12
Bio Techne USD 2.67B 65.59M 2024-12
Bio-Rad Laboratories USD 9.36B 1.24B 2024-12
Boston Scientific USD 39.4B 1.32B 2024-12
Bruker USD 5.81B 302.5M 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Danaher USD 79.12B 1.57B 2025-03
Dentsply International USD 5.75B 873M 2024-12
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Exact Sciences USD 5.93B 820.43M 2024-12
General Electric USD 124.12B 983M 2025-03
Henry Schein USD 10.22B 387M 2024-12
Hologic USD 8.73B 427.3M 2024-12
Illumina USD 6.3B 289M 2024-12
Intuitive Surgical USD 19.22B 477.2M 2025-03
IQVIA Holdings USD 26.9B 281M 2024-12
Laboratory Of America USD 17.6B 775.2M 2025-03
Medtronic USD 89.97B 69M 2025-01
Mettler Toledo International USD 3.24B 79.83M 2024-12
Myriad Genetics USD 1.03B 53.7M 2024-12
Olympus JPY 1.41T 40.29B 2024-12
Quest Diagnostics USD 15.8B 356M 2025-03
Repligen USD 2.85B 22.48M 2025-03
Revvity USD 12.36B 31.75M 2025-03
Stryker USD 42.97B 862M 2024-12
Thermo Fisher Scientific USD 99.04B 1.72B 2025-03
Veracyte USD 1.3B 25.01M 2024-12
Waters USD 4.55B 42.18M 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12



Thermo Fisher Scientific الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.